Hot Topics

Poll

Why is it a big mistake to link funding of R&D costs with drug prices?:

Karl De Gucht writes Andris Piebalgs on topic of European Union IPR demands on India and other developing countries

KEI has received a copy of a May 16, 2011 letter from Karl De Gucht to Andris Piebalgs, which discusses (1) the EU-India FTA, and (2) Relations between IPR and development policies.

Senator Sanders introduces two medical innovation prize bills in U.S. Senate to de-link R&D costs from drug prices

Sanders_IMG_3442.jpgOn Thursday, May 26, 2011, Senator Bernie Sanders (I-VT) introduced two bills in the United States Senate that would de-link R&D costs from drug prices. The bill names and numbers are as follows:

  • The Medical Innovation Prize Fund Act: S. 1137
  • The Prize Fund for HIV/AIDS Act: S. 1138

KEI Technical Meeting to Discuss Innovation Inducement Prizes, June 3, 2011

There is a growing interest in the use of innovation inducement prizes to stimulate investments in medical research and development.

  • The Obama Administration and the European Commission are exploring the role of innovation inducement prizes.
  • On May 31, 2011, the European Parliament is holding one of several meetings on innovation inducement prizes for medical technologies.

Draft WHO Executive Board resolution on WHO reform

At 18:30 Geneva time on 25 May 2011, during the 129th session of the WHO Executive Board, the EB is considering the following draft decision on WHO reform.

Chair's text, based on draft proposed by Ecuador

The 29th [sic] Executive Board,

(OP.1) DECIDES to establish an incremental, transparent, Member-State driven and inclusive consultative process comprising of the following elements:

Letter to the 129th WHO Executive Board on conflicts of interest, WHO reform and the future of financing

24 May 2011

NGO letter on Conflicts of Interest, Future Financing, Reform and governance of the WHO.

Dear Members of the Executive Board,

SCP 16: Summary by the Chair


WIPO
World Intellectual Property Organization

SCP/16/8 PROV.
ORIGINAL: ENGLISH
DATE: MAY 20, 2011

Standing Committee on the Law of Patents

Sixteenth Session
Geneva, May 16 to 20, 2011

SUMMARY BY THE CHAIR

Agenda Item 1: Opening of the session

1. The sixteenth of the Standing Committee on the Law of Patents (SCP) was opened by Mr. James Pooley, Deputy Director General, who welcomed the participants. Mr. Philippe Baechtold (WIPO) acted as Secretary.

BRICS Health Ministers’ preparatory meeting – May 17th 2011

BRICS Health Ministers’ preparatory meeting – May 17th 2011
Press release

Consistent with the mandate of the Sanya Declaration of the BRICS Leaders Meeting (14 April 2011), the Ministers of Health of the five BRICS’ countries met on the sidelines of the 64thWorld Health Assembly, on 17 May 2011, to discuss issues of common interest as well as prepare the BRICS Health Ministerial Meeting to be held in Beijing, China, on 11 July 2011. Representatives of WHO and UNAIDS also attended the meeting.

SCP16: KEI intervention on Patents and Health

16th session of the WIPO Standing Committee of the Law of Patents (SCP)
Thursady, 19 May 2011

KEI Statement on Patents and Health

KEI is impressed by and fully supportive of the joint proposal of the African Group and the Development Agenda Group on a work program on Patents and Health, which has been published as SCP/16/7. We agree with the comments of the Chair that the proposal is both comprehensive and well thought out.

Brazil's statement to the 64th World Health Assembly on the future of financing

64TH WORLD HEALTH ASSEMBLY
The future of financing for WHO A64/4
WHO REFORM AGENDA
Provisional agenda item 11

STATEMENT BY THE BRAZILIAN DELEGATION

At the outset we would like to thank the report by the Director-General on WHO reform and its future financing for a healthy future. We acknowledge the efforts to reflect comments and suggestions presented by Member-States throughout the ongoing consultation process and believe the document is a good basis for our continued debate on this important issue.

USPTO statement at WIPO side event on Medicines Patent Pool

This is the statement that was delivered by Karin L. Ferriter (from USPTO and USTR), at a UNITAID side event on the Medicines Patent Pool, during a break of the WIPO Standing Committee on the Law of Patents.

Statement on Medicines Patent Pool Side Event

NGO Statement on WHO governance and the Management of Conflicts of Interest and the Future of Financing for WHO

NGO Statement on WHO governance and the Management of Conflicts of Interest and the Future of Financing for WHO.

May 18, 2011

We write to express our concerns about governance of the World Health Organization (WHO) and other public health bodies, as regards the management of conflicts of interest.

SCP16: Slide presentations of Professor Carlos Correa, Judit Rius Sanjuan and James Love at KEI briefing on Patents and Health

On 17 May 2011, Knowledge Ecology International (KEI) organized a Briefing on Patents and Health at WIPO’s 16h session of the Standing Committee on Patents (SCP).

KEI comments to the WIPO patent committee discussion of patent quality

During today's discussion at the WIPO Standing Committee on the Law of Patents (SCP) on patent quality KEI make four points in its intervention.

1. WIPO should consider gathering information on the costs of litigation to challenge the validity of patents.

2. WIPO should consider creating a database to share information on the cases where litigation has resulted findings that patent claims as invalid.

Syndicate content